Parimal Kumar Sunil Prabhu
-
{
- All
- News
-
PM's Meeting Today On Covid Amid Concerns Over New Strain 'Omicron'
Prime Minister Narendra Modi is chairing a meeting, attended by top government officials, on the COVID-19 and vaccination situation in the country.
-
12 To 16-Week Gap For Covishield Doses, Says Government
The gap between the first and second doses of the Covishield COVID-19 vaccine can be increased to 12-16 weeks - from the existing six-eight weeks - the government said Thursday, adding that there are no recommended changes in Covaxin dosage interval
-
Covaxin Phase 2, 3 Clinical Trials For 2-18 Age Group Cleared
Covaxin trials on children from two to 18 years were cleared by the Drugs Controller General of India (DCGI) today. This is the first time in India that a Covid vaccine will be tested on children.
-
Word 'Indian' Not In WHO Report On Covid Variant: Government Fact-Checks
The government today objected to the labelling of the B.1.617 Covid variant as an "Indian variant", stressing that the word "Indian" was never used by the World Health Organisation (WHO).
-
India Allows Use Of Low-Cost Steroid To Treat Coronavirus Patients
The government on Saturday allowed the use of the low-cost steroid drug dexamethasone as an alternative to methylprednisolone to treat coronavirus patients with moderate and severe symptoms. The World Health Organization had called for a rapid increase in production of dexamethasone, after British clinical trials found it had life-saving potential ...
-
115 President's Estate Families Isolated As Worker's Relative Tests COVID-19 +ve
Residents of 115 houses in the Rashtrapati Bhavan complex have been quarantined after the relative of an employee there tested positive for coronavirus, sources said. No employee of President's Secretariat has tested positive for COVID-19, a Rashtrapati Bhavan statement said.
-
PM's Meeting Today On Covid Amid Concerns Over New Strain 'Omicron'
Prime Minister Narendra Modi is chairing a meeting, attended by top government officials, on the COVID-19 and vaccination situation in the country.
-
12 To 16-Week Gap For Covishield Doses, Says Government
The gap between the first and second doses of the Covishield COVID-19 vaccine can be increased to 12-16 weeks - from the existing six-eight weeks - the government said Thursday, adding that there are no recommended changes in Covaxin dosage interval
-
Covaxin Phase 2, 3 Clinical Trials For 2-18 Age Group Cleared
Covaxin trials on children from two to 18 years were cleared by the Drugs Controller General of India (DCGI) today. This is the first time in India that a Covid vaccine will be tested on children.
-
Word 'Indian' Not In WHO Report On Covid Variant: Government Fact-Checks
The government today objected to the labelling of the B.1.617 Covid variant as an "Indian variant", stressing that the word "Indian" was never used by the World Health Organisation (WHO).
-
India Allows Use Of Low-Cost Steroid To Treat Coronavirus Patients
The government on Saturday allowed the use of the low-cost steroid drug dexamethasone as an alternative to methylprednisolone to treat coronavirus patients with moderate and severe symptoms. The World Health Organization had called for a rapid increase in production of dexamethasone, after British clinical trials found it had life-saving potential ...
-
115 President's Estate Families Isolated As Worker's Relative Tests COVID-19 +ve
Residents of 115 houses in the Rashtrapati Bhavan complex have been quarantined after the relative of an employee there tested positive for coronavirus, sources said. No employee of President's Secretariat has tested positive for COVID-19, a Rashtrapati Bhavan statement said.
